Clinical Trial

Role of Plasma Rich Growth Factor in Repair Primary Cleft Palate

Name: Role of Plasma Rich Growth Factor in Repair Primary Cleft Palate — clinical trial record (NCT06889181)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PRGF

Not Yet Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated March 21, 2025 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

Does the plasma-rich growth factor (PRGF) with primary cleft palate repair accelerate wound healing and prevent post-operative oronasal fistula occurrence?

Trial Details

NCT Number	NCT06889181
Lead Sponsor	Cairo University
Conditions	Cleft Palate, Plasma Rich in Growth Factors
Enrollment	36 participants
Start Date	2025-04-01
Primary Completion	2025-07-30 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-03-21